Nearly two dozen state attorneys general sent a letter to Food and Drug Administration (FDA) Commissioner Dr. Robert Califf on Friday, urging the agency to reverse its “illegal and dangerous” decision to abandon certain restrictions concerning abortion pills.
The Food and Drug Administration (FDA) eased restrictions Thursday on at-home drug-induced abortions by allowing women and girls to end their pregnancies via mail-order pills without having to see an abortion provider in person.
The FDA lifted restrictions on abortion-inducing drugs, allowing for dispensation through telemedicine and the mail during the pandemic.
Planned Parenthood of Arizona has quietly dropped its 2019 lawsuit against three state abortion restrictions.
Kansas Sen. Barbara Bollier (D) voted against a bipartisan bill that temporarily expanded telemedicine during the pandemic, but she supported the expansion of tele-abortions, enabling more women and girls to perform their own at-home, drug-induced abortions.
Hollywood screenwriter Merritt Tierce and executive producer Neal Baer are urging their industry colleagues to produce more “abortion stories” in order to make having the procedure appear more normal.
More than 90 members of Congress have written to Food and Drug Administration (FDA) Commissioner Stephen Hahn, urging him to classify the abortion drug Mifeprex (mifepristone) as a “hazard” or “threat of danger” in order to have it removed from the U.S. market.
A federal judge ruled women may buy abortion drugs without an in-person medical examination during the remainder of the coronavirus pandemic.
The American Civil Liberties Union (ACLU) filed a federal lawsuit Wednesday challenging a Food and Drug Administration (FDA) rule that requires women to have an in-person clinic visit in order to obtain drugs to induce an abortion.
The acting CEO of Planned Parenthood said the “silver lining” of the pandemic is that her abortion chain has used telehealth technology to provide drug-induced, at-home abortions.
